Light Sciences Oncology Inc
Funding rounds
4 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jan 2019 | $2 M | No. 4 | $2 to $10 million | equity | SEC | |
| Jan 2012 | $1 M | No. 3 | Under $2 million | equity | SEC | |
| Jun 2011 | $6 M | No. 2 | $2 to $10 million | debt, options | SEC | |
| Oct 2009 | $35 M | No. 1 | $10 to $50 million | debt, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Light Sciences Oncology Inc chose not to state its revenue in its newest notice of a funding round (Jan 2019).
SEC Form D · Jan 2019
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jan 2019
That is all the official record says: Light Sciences Oncology Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Light Sciences Oncology Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 17 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Llew Keltner | Executive officer | Jan 2019 |
| Robert Littauer | Executive officer | Jan 2019 |
| Dennis Langer | Executive officer | Jan 2012 |
| Lisa I. Koch-Hulle | Executive officer | Jan 2012 |
| Robert M. Littauer | Executive officer | Jan 2012 |
| Dennis P. Langer | Executive officer | Jun 2011 |
| James C. Chen | Executive officer | Jun 2011 |
| Martin P. Olin | Executive officer | Jun 2011 |
| Sy-Shi I. Wang | Executive officer | Jun 2011 |
| James C Chen | Executive officer | Nov 2009 |
| Lisa C Koch-Hulle | Executive officer | Nov 2009 |
| Llew Keltner, M.D. Ph.D. | Executive officer | Nov 2009 |
| Robert M Littauer | Executive officer | Nov 2009 |
| S Erik C Hagstrom | Executive officer | Nov 2009 |
| Sy-Shi C Wang | Executive officer | Nov 2009 |
| Dennis Langer | Director | Jan 2019 |
| Edward Avedisian | Director | Jan 2019 |
| Llew Keltner | Director | Jan 2019 |
| Mortimer Sackler | Director | Jan 2019 |
| Thomas Lavin | Director | Jan 2019 |
| Akbar Seddigh | Director | Jan 2012 |
| Jeff Himawan | Director | Jan 2012 |
| Martin Olin | Director | Jan 2012 |
| Peter Bisgaard | Director | Jan 2012 |
| Akbar P. Seddigh | Director | Jun 2011 |
| David P. Holveck | Director | Jun 2011 |
| Dennis P. Langer | Director | Jun 2011 |
| Frank E. Young | Director | Jun 2011 |
| Martin P. Olin | Director | Jun 2011 |
| Mitchell P. Hymowitz | Director | Jun 2011 |
| Terry Gould | Director | Jun 2011 |
| Craig P Watjen | Director | Nov 2009 |
| David P Holveck | Director | Nov 2009 |
| Frank E Young, M.D., Ph.D. | Director | Nov 2009 |
| Jeff C Himawan, Ph.D. | Director | Nov 2009 |
| Llew Keltner, M.D. Ph.D. | Director | Nov 2009 |
| Martin P Olin | Director | Nov 2009 |
| Peter C Bisgaard | Director | Nov 2009 |
| Richard K Whitney | Director | Nov 2009 |
| Terry C Gould | Director | Nov 2009 |